Acquired obesity increases CD68 and tumor necrosis factor-α and decreases adiponectin gene expression in adipose tissue: A study in monozygotic twins

Journal of Clinical Endocrinology and Metabolism

Volumn 91, Issue 7, 2006, Pages 2776-2781

  Pietiläinen, Kirsi H ^a,b,f   Kannisto, Katja ^c   Korsheninnikova, Elena ^d   Rissanen, Aila ^a   Kaprio, Jaakko ^b,e   Ehrenborg, Ewa ^c   Hamsten, Anders ^c   Yki Järvinen, Hannele ^a,c,d  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c KAROLINSKA INSTITUTE   (Sweden)

^d MINERVA FOUNDATION INSTITUTE FOR MEDICAL RESEARCH   (Finland)

^e NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^f Department of Medicine   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; CD68 ANTIGEN; FAT; LEPTIN; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; ADIPOSE TISSUE; ADULT; ARTICLE; BIOPSY; BODY FAT; BODY MASS; BODY WEIGHT; CELL SIZE; CLINICAL ARTICLE; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; GLUCOSE CLAMP TECHNIQUE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MONOZYGOTIC TWINS; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPECTROSCOPY;

ADIPOCYTES; ADIPONECTIN; ADIPOSE TISSUE; ADULT; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BODY COMPOSITION; CELL SIZE; DENSITOMETRY, X-RAY; FEMALE; GENE EXPRESSION; GLUCOSE CLAMP TECHNIQUE; HUMANS; INSULIN RESISTANCE; MALE; OBESITY; POLYMERASE CHAIN REACTION; PPAR GAMMA; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA; TWINS, MONOZYGOTIC;

EID: 33745787051     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2005-2848     Document Type: Article

References (39)

1. Lyon CJ, Law RE, Hsueh WA 2003 Minireview: adiposity, inflammation, and atherogenesis. Endocrinology 144:2195-2200
2. Bouloumie A, Curat CA, Sengenes C, Lolmede K, Miranville A, Busse R 2005 Role of macrophage tissue infiltration in metabolic diseases. Curr Opin Clin Nutr Metab Care 8:347-354
3. Sethi JK, Hotamisligil GS 1999 The role of TNFα in adipocyte metabolism. Semin Cell Dev Biol 10:19-29
4. Hukshorn CJ, Saris WH 2004 Leptin and energy expenditure. Curr Opin Clin Nutr Metab Care 7:629-633
5. Couillard C, Mauriege P, Imbeault P, Prud'homme D, Nadeau A, Tremblay A, Bouchard C, Despres JP 2000 Hyperleptinemia is more closely associated with adipose cell hypertrophy than with adipose tissue hyperplasia. Int J Obes Relat Metab Disord 24:782-788
6. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, Ezaki O, Akanuma Y, Gavrilova O, Vinson C, Reitman ML, Kagechika H, Shudo K, Yoda M, Nakano Y, Tobe K, Nagai R, Kimura S, Tomita M, Froguel P, Kadowaki T 2001 The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7:941-946
7. Ajuwon KM, Spurlock ME 2005 Adiponectin inhibits LPS-induced NF-κB activation and IL-6 production and increases PPARγ2 expression in adipocytes. Am J Physiol Regul Integr Comp Physiol 288:R1220-R1225
8. Kaprio J, Pulkkinen L, Rose RJ 2002 Genetic and environmental factors in health-related behaviors: studies on Finnish twins and twin families. Twin Res 5:366-371
9. Pietiläinen KH, Rissanen A, Kaprio J, Mäkimattila S, Häkkinen AM, Westerbacka J, Sutinen J, Vehkavaara S, Yki-Järvinen H 2005 Acquired obesity is associated with increased liver fat, intra-abdominal fat, and insulin resistance in young adult monozygotic twins. Am J Physiol Endocrinol Metab 288:E768-E774
10. Gertow K, Pietiläinen KH, Yki-Järvinen H, Kaprio J, Rissanen A, Eriksson P, Hamsten A, Fisher RM 2004 Expression of fatty-acid-handling proteins in human adipose tissue in relation to obesity and insulin resistance. Diabetologia 47:1118-1125
11. Kannisto K, Pietiläinen KH, Ehrenborg E, Rissanen A, Kaprio J, Hamsten A, Yki-Järvinen H 2004 Overexpression of 11β-hydroxysteroid dehydrogenase-1 in adipose tissue is associated with acquired obesity and features of insulin resistance: studies in young adult monozygotic twins. J Clin Endocrinol Metab 89:4414-4421
12. Pietiläinen KH, Rissanen A, Laamanen M, Lindholm AK, Markkula H, Yki-Järvinen H, Kaprio J 2004 Growth patterns in young adult monozygotic twin pairs discordant and concordant for obesity. Twin Res 7:421-429
13. Yki-Järvinen H, Nikkilä EA, Kubo K, Foley JE 1986 Assay of glucose transport in human fat cells obtained by needle biopsy. Diabetologia 29:287-290
14. Mazess RB, Barden HS, Bisek JP, Hanson J 1990 Dual-energy x-ray absorptiometry for total-body and regional bone-mineral and soft-tissue composition. Am J Clin Nutr 51:1106-1112
15. Ryysy L, Häkkinen AM, Goto T, Vehkavaara S, Westerbacka J, Halavaara J, Yki-Järvinen H 2000 Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients. Diabetes 49:749-758
16. Sutinen J, Korsheninnikova E, Funahashi T, Matsuzawa Y, Nyman T, Yki-Järvinen H 2003 Circulating concentration of adiponectin and its expression in subcutaneous adipose tissue in patients with highly active antiretroviral therapy-associated lipodystrophy. J Clin Endocrinol Metab 88:1907-1910
17. Kannisto K, Sutinen J, Korsheninnikova E, Fisher RM, Ehrenborg E, Gertow K, Virkamäki A, Nyman T, Vidal H, Hamsten A, Yki-Järvinen H 2003 Expression of adipogenic transcription factors, peroxisome proliferator- activated receptor γ coactivator 1, IL-6 and CD45 in subcutaneous adipose tissue in lipodystrophy associated with highly active antiretroviral therapy. AIDS 17: 1753-1762
18. Sutinen J, Kannisto K, Korsheninnikova E, Fisher RM, Ehrenborg E, Nyman T, Virkamäki A, Funahashi T, Matsuzawa Y, Vidal H, Hamsten A, Yki-Järvinen H 2004 Effects of rosiglitazone on gene expression in subcutaneous adipose tissue in highly active antiretroviral therapy-associated lipodystrophy. Am J Physiol Endocrinol Metab 286:E941-E949
19. Yki-Järvinen H, Sutinen J, Silveira A, Korsheninnikova E, Fisher RM, Kannisto K, Ehrenborg E, Eriksson P, Hamsten A 2003 Regulation of plasma PAI-1 concentrations in HAART-associated lipodystrophy during rosiglitazone therapy. Arterioscler Thromb Vasc Biol 23:688-694
20. Way JM, Harrington WW, Brown KK, Gottschalk WK, Sundseth SS, Mansfield TA, Ramachandran RK, Willson TM, Kliewer SA 2001 Comprehensive messenger ribonucleic acid profiling reveals that peroxisome proliferator-activated receptor γ activation has coordinate effects on gene expression in multiple insulin-sensitive tissues. Endocrinology 142:1269-1277
21. Desbuquois B, Aurbach GD 1971 Use of polyethylene glycol to separate free and antibody-bound peptide hormones in radioimmunoassays. J Clin Endocrinol Metab 33:732-738
22. Martin N, Boomsma D, Machin G 1997 A twin-pronged attack on complex traits. Nat Genet 17:387-392
23. Williams RL 2000 A note on robust variance estimation for cluster-correlated data. Biometrics 56:645-646
24. Yang X, Jansson PA, Nagaev I, Jack MM, Carvalho E, Sunnerhagen KS, Cam MC, Cushman SW, Smith U 2004 Evidence of impaired adipogenesis in insulin resistance. Biochem Biophys Res Commun 317:1045-1051
25. De Souza CJ, Eckhardt M, Gagen K, Dong M, Chen W, Laurent D, Burkey BF 2001 Effects of pioglitazone on adipose tissue remodeling within the setting of obesity and insulin resistance. Diabetes 50:1863-1871
26. Giusti V, Verdumo C, Suter M, Gaillard RC, Burckhardt P, Pralong F 2003 Expression of peroxisome proliferator-activated receptor-γ1 and peroxisome proliferator-activated receptor-γ2 in visceral and subcutaneous adipose tissue of obese women. Diabetes 52:1673-1676
27. Ribiere C, Plut C 2005 Nutritional regulation of leptin signaling. Curr Hypertens Rep 7:11-16
28. Clement K, Viguerie N, Poitou C, Carette C, Pelloux V, Curat CA, Sicard A, Rome S, Benis A, Zucker JD, Vidal H, Laville M, Barsh GS, Basdevant A, Stich V, Cancello R, Langin D 2004 Weight loss regulates inflammation-related genes in white adipose tissue of obese subjects. FASEB J 18:1657-1669
29. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante Jr AW 2003 Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112:1796-1808
30. Christiansen T, Richelsen B, Bruun JM 2005 Monocyte chemoattractant protein-1 is produced in isolated adipocytes, associated with adiposity and reduced after weight loss in morbid obese subjects. Int J Obes Relat Metab Disord 29:146-150
31. Di Gregorio GB, Yao-Borengasser A, Rasouli N, Varma V, Lu T, Miles LM, Ranganathan G, Peterson CA, McGehee RE, Kern PA 2005 Expression of CD68 and macrophage chemoattractant protein-1 genes in human adipose and muscle tissues: association with cytokine expression, insulin resistance, and reduction by pioglitazone. Diabetes 54:2305-2313
32. Wang B, Jenkins JR, Trayhurn P 2005 Expression and secretion of inflammation-related adipokines by human adipocytes differentiated in culture: integrated response to TNFα. Am J Physiol Endocrinol Metab 288:E731-E740
33. Bruun JM, Lihn AS, Verdich C, Pedersen SB, Toubro S, Astrup A, Richelsen B 2003 Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans. Am J Physiol Endocrinol Metab 285: E527-E533
34. Mohamed-Ali V, Goodrick S, Rawesh A, Katz DR, Miles JM, Yudkin JS, Klein S, Coppack SW 1997 Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-α, in vivo. J Clin Endocrinol Metab 82:4196-4200
35. Westerbacka J, Corner A, Tiikkainen M, Tamminen M, Vehkavaara S, Häkkinen AM, Fredriksson J, Yki-Järvinen H 2004 Women and men have similar amounts of liver and intra-abdominal fat, despite more subcutaneous fat in women: implications for sex differences in markers of cardiovascular risk. Diabetologia 47:1360-1369
36. Yki-Järvinen H, Westerbacka J 2005 The fatty liver and insulin resistance. Curr Mol Med 5:287-295
37. Bugianesi E, Pagotto U, Manini R, Vanni E, Gastaldelli A, De Iasio R, Gentilcore E, Natale S, Cassader M, Rizzetto M, Pasquali R, Marchesini G 2005 Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity. J Clin Endocrinol Metab 90:3498-3504
38. Cai D, Yuan M, Frantz DF, Melendez PA, Hansen L, Lee J, Shoelson SE 2005 Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB. Nat Med 11:183-190
39. Westerbacka J, Lammi K, Häkkinen AM, Rissanen A, Salminen I, Aro A, Yki-Järvinen H 2005 Dietary fat content modifies liver fat in overweight nondiabetic subjects. J Clin Endocrinol Metab 90:2804-2809